Subcutaneous ianalumab safe and effective for Sjogren's syndrome: Lancet Medha Baranwal6 Dec 2021 9:00 AM ISTUSA: Findings from a recent trial showed ianalumab to be safe and well-tolerated in patients with moderate to severe primary Sjogren's syndrome. The...
Children with type 2 diabetes at higher risk of developing retinopathy than those with T1D: JAMA Medha Baranwal4 Dec 2021 10:00 AM ISTUSA: Findings from a recent study in the journal JAMA Ophthalmology suggest that children with (T2D) are at a higher risk of developing...
Tigulixostat lowers uric acid levels in gout patients with hyperuricemia: Study Medha Baranwal4 Dec 2021 9:00 AM ISTUSA: Tigulixostat significantly lowers the levels of serum uric acid (sUA) in gout patients with hyperuricemia versus placebo at all dose levels,...
Sacubitril-valsartan not tied to lower death risk versus ramipril in acute myocardial infarction: Study Medha Baranwal4 Dec 2021 9:00 AM ISTUSA: A recent study suggests that in patients with acute myocardial infarction, sacubitril-valsartan did not significantly lower death risk from...
9-Hole Peg Test useful for detecting motor impairments in multiple sclerosis patients: Study Medha Baranwal4 Dec 2021 9:00 AM ISTUSA: The 9-Hole Peg Test could be a useful tool for assessing motor impairments in patients with multiple sclerosis (MS), suggests a recent study....
Geriatric assessment and management reduces toxic effects of cancer treatment in elderly: Lancet Medha Baranwal4 Dec 2021 9:00 AM ISTreduced the incidence of grade 3 toxicity
Deep learning algorithm cuts spine MRI exam time by about 50 percent, study finds Medha Baranwal4 Dec 2021 9:00 AM ISTUSA: The use of a deep learning algorithm for reconstructing spine MRI exams gives images comparable to those taken with a conventional MRI, reveals a...
Hyperglycemia tied to stent restenosis in STEMI patients undergoing PCI: Study Medha Baranwal3 Dec 2021 10:00 AM ISTNew York, NY: A recent study in the journal Diabetes Care indicates that hyperglycemia (HG) is associated with adverse outcomes in STEMI patients...
Obicetrapib given with high-intensity statins reduces LDL-C by 50 percent: Study Medha Baranwal3 Dec 2021 9:15 AM ISTUSA: Obicetrapib at doses of 5 and 10 mg largely reduced LDL-C in patients treated with high-intensity statins, according to results from the Rose...
Vismodegib effective against advanced basal cell carcinoma, finds study Medha Baranwal3 Dec 2021 9:00 AM ISTCanada: A recent study has reported vismodegib to be an effective treatment for advanced basal cell carcinoma (aBCC); however, toxicity remained an...
PET imaging reliable for evaluating new cancer therapies: Study Medha Baranwal3 Dec 2021 9:00 AM ISTUSA: According to a recent study in the Journal of Nuclear Medicine, FAPi PET imaging of cancer patients with a gallium-68 (Ga-68) tracer may be...
Sacubitril/valsartan decreases plasma NT-proBNP in HF patients with preserved ejection fraction: JAMA Medha Baranwal3 Dec 2021 9:00 AM ISTGermany: Sacubitril/valsartan significantly decreased plasma NT-proBNP levels at 12 weeks compared with standard medical therapies in patients with...
